INTENSIV-News
Effect of mechanical ventilation on inflammatory mediators in
patients with acute respiratory distress syndrome: a randomized
controlled trial
Ranieri VM, Suter PM, Tortorella C, et
al. JAMA 1999; 282:54-61
Istituto di Anestesiologia e Rianimazione, Universita di Bari, Ospedale Policlinico, Italy.
CONTEXT:
Studies have shown that an inflammatory response may be elicited by
mechanical ventilation used for recruitment or derecruitment of
collapsed lung units or to overdistend alveolar regions, and that a
lung-protective strategy may reduce this response.
OBJECTIVE: To
test the hypothesis that mechanical ventilation induces a pulmonary and
systemic cytokine response that can be minimized by limiting recruitment
or derecruitment and overdistention.
DESIGN AND SETTING: Randomized
controlled trial in the intensive care units of 2 European hospitals
from November 1995 to February 1998, with a 28-day follow-up.
PATIENTS:
Forty-four patients (mean [SD] age, 50 [18] years) with acute
respiratory distress syndrome were enrolled, 7 of whom were withdrawn
due to adverse events.
INTERVENTIONS: After admission,
volume-pressure curves were measured and bronchoalveolar lavage and
blood samples were obtained. Patients were randomized to either the
control group (n = 19): tidal volume to obtain normal values of arterial
carbon dioxide tension (35-40 mm Hg) and positive end-expiratory
pressure (PEEP) producing the greatest improvement in arterial oxygen
saturation without worsening hemodynamics; or the lung-protective
strategy group (n = 18): tidal volume and PEEP based on the
volume-pressure curve. Measurements were repeated 24 to 30 and 36 to 40
hours after randomization.
MAIN OUTCOME MEASURES: Pulmonary and
systemic concentrations of inflammatory mediators approximately 36 hours
after randomization.
RESULTS: Physiological characteristics and
cytokine concentrations were similar in both groups at randomization.
There were significant differences (mean [SD]) between the control and
lung-protective strategy groups in tidal volume (11.1 [1.3] vs 7.6 [1.1]
mL/kg), end-inspiratory plateau pressures (31.0 [4.5] vs 24.6 [2.4] cm
H2O), and PEEP (6.5 [1.7] vs 14.8 [2.7] cm H2O) (P<.001). Patients in
the control group had an increase in bronchoalveolar lavage
concentrations of interleukin (IL) 1beta, IL-6, and IL-1 receptor
agonist and in both bronchoalveolar lavage and plasma concentrations of
tumor necrosis factor (TNF) alpha, IL-6, and TNF-alpha, receptors over
36 hours (P<.05 for all). Patients in the lung-protective strategy
group had a reduction in bronchoalveolar lavage concentrations of
polymorphonuclear cells, TNF-alpha, IL-1beta, soluble TNF-alpha receptor
55, and IL-8, and in plasma and bronchoalveolar lavage concentrations
of IL-6, soluble TNF-alpha receptor 75, and IL-1 receptor antagonist
(P<.05). The concentration of the inflammatory mediators 36 hours
after randomization was significantly lower in the lung-protective
strategy group than in the control group (P<.05).
CONCLUSIONS:
Mechanical ventilation can induce a cytokine response that may be
attenuated by a strategy to minimize overdistention and
recruitment/derecruitment of the lung. Whether these physiological
improvements are associated with improvements in clinical end points
should be determined in future studies.
Eine der grundlegenden Entwicklungen in der Beatmungstherapie der letzten Jahre war, dass "die Beatmung an den Patienten angepasst wird und nicht der Patient an die Beatmung". Jede nicht patientenadaptierte Beatmung führt zu schwerwiegenden Nebenwirkungen, zu psychischem Stress, ("the patient fighting the ventilator"), aber auch zu einem breiten Spektrum von verschiedenen anderen Komplikationen. Wie diese beatmungsbedingte Lungenschädigungen vermieden werden können, ist eines der zentralen Forschungsgebiete der Intensivmedizin. Dabei haben sich insbesondere Maßnahmen der "sanften Beatmung", wie das Limitieren des Zugvolumens, der maximalen Druckwerte, die Optimierung des PEEP auf niedere Niveaus, die Reduktion der O2-Konzentration etc. durchgesetzt und dazu beigetragen, dass das Auftreten beatmungsbedingter Komplikationen vermindert werden konnte.
Wir wollen Fachärzte und Pfleger topaktuell und wissenschaftlich fundiert über Studien, fachspezifische Entwicklungen und deren praktische Umsetzung informieren, um sie in ihrer Arbeit und Fortbildung zu unterstützen.
Wählen Sie dazu bitte Ihr Land aus.